Description
MGCD0103 (Mocetinostat) is a class I selective HDAC inhibitor that inhibits HDAC1, HDAC2 and HDAC3 with IC₅₀ values of 0.15, 0.29 and 1.66 µM, respectively. Displays anticancer activities.
MGCD0103 (Mocetinostat) is a class I selective HDAC inhibitor that inhibits HDAC1, HDAC2 and HDAC3 with IC₅₀ values of 0.15, 0.29 and 1.66 µM, respectively. Displays anticancer activities.
Alternate Name/Synonyms: N-(2-Aminophenyl)-4-[[[4-(3-pyridinyl)-2-pyrimidinyl]amino]methyl]benzamide; Mocetinostat; MG0103
Appearance: White to off-white solid
Formulation: N/A
CAS Number: 726169-73-9
Structure Available?: Y
Peptide sequence: N/A
Salt Form: No
Molecular Formula: C₂₃H₂₀N₆O
Molecular Weight: 396.44
Cell-Permeable?: Yes
Purity: >98% by HPLC
Solubilities: DMSO
Handling: Protect from air and light
Country of Origin: USA
Tag Line: A potent class I selective HDAC inhibitor
MDL Number: N/A
PubChem CID: 9865515
SMILES: C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC3=NC=CC(=N3)C4=CN=CC=C4
InChi: InChI=1S/C23H20N6O/c24-19-5-1-2-6-21(19)28-22(30)17-9-7-16(8-10-17)14-27-23-26-13-11-20(29-23)18-4-3-12-25-15-18/h1-13,15H,14,24H2,(H,28,30)(H,26,27,29)
InChi Key: HRNLUBSXIHFDHP-UHFFFAOYSA-N
Additional Information
Storage Condition: |
-20 ̊C |
Shipping Condition: |
Gel Pack |
Shelf Life: |
36 months |